Published in J Antimicrob Chemother on September 01, 2003
Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev (2008) 17.77
AmpC beta-lactamases. Clin Microbiol Rev (2009) 7.14
OXA-58, a novel class D {beta}-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob Agents Chemother (2005) 3.63
Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii. Antimicrob Agents Chemother (2005) 3.41
Characterization of the naturally occurring oxacillinase of Acinetobacter baumannii. Antimicrob Agents Chemother (2005) 3.25
Modes and modulations of antibiotic resistance gene expression. Clin Microbiol Rev (2007) 2.66
Genetics and expression of the carbapenem-hydrolyzing oxacillinase gene blaOXA-23 in Acinetobacter baumannii. Antimicrob Agents Chemother (2007) 2.30
Genetic structures at the origin of acquisition and expression of the carbapenem-hydrolyzing oxacillinase gene blaOXA-58 in Acinetobacter baumannii. Antimicrob Agents Chemother (2006) 2.24
OXA β-lactamases. Clin Microbiol Rev (2014) 1.95
Multidrug resistant acinetobacter. J Glob Infect Dis (2010) 1.94
Molecular characterization of cefoxitin-resistant Escherichia coli from Canadian hospitals. Antimicrob Agents Chemother (2005) 1.74
Acinetobacter baumannii: an emerging opportunistic pathogen. Virulence (2012) 1.63
Functional analysis of insertion sequence ISAba1, responsible for genomic plasticity of Acinetobacter baumannii. J Bacteriol (2009) 1.57
Genetic environment and transcription of ampC in an Acinetobacter baumannii clinical isolate. Antimicrob Agents Chemother (2004) 1.57
Insertion sequence ISAba11 is involved in colistin resistance and loss of lipopolysaccharide in Acinetobacter baumannii. Antimicrob Agents Chemother (2011) 1.41
Multidrug-resistant Acinetobacter spp.: increasingly problematic nosocomial pathogens. Yonsei Med J (2011) 1.29
VEB-1 Extended-spectrum beta-lactamase-producing Acinetobacter baumannii, France. Emerg Infect Dis (2006) 1.29
In vivo selection of reduced susceptibility to carbapenems in Acinetobacter baumannii related to ISAba1-mediated overexpression of the natural bla(OXA-66) oxacillinase gene. Antimicrob Agents Chemother (2009) 1.20
Genomic comparison of multi-drug resistant invasive and colonizing Acinetobacter baumannii isolated from diverse human body sites reveals genomic plasticity. BMC Genomics (2011) 1.18
Genomic analysis of Acinetobacter baumannii A118 by comparison of optical maps: identification of structures related to its susceptibility phenotype. Antimicrob Agents Chemother (2011) 1.16
Comparative genomic analysis of rapid evolution of an extreme-drug-resistant Acinetobacter baumannii clone. Genome Biol Evol (2013) 1.12
Acinetobacter baumannii increases tolerance to antibiotics in response to monovalent cations. Antimicrob Agents Chemother (2009) 1.08
Molecular epidemiology of Acinetobacter baumannii bloodstream isolates obtained in the United States from 1995 to 2004 using rep-PCR and multilocus sequence typing. J Clin Microbiol (2012) 1.04
Genetic basis of multidrug resistance in Acinetobacter clinical isolates in Taiwan. Antimicrob Agents Chemother (2010) 0.98
Dissemination of multidrug resistant Acinetobacter baumannii in various hospitals of Antananarivo Madagascar. Ann Clin Microbiol Antimicrob (2010) 0.94
A novel method of consensus pan-chromosome assembly and large-scale comparative analysis reveal the highly flexible pan-genome of Acinetobacter baumannii. Genome Biol (2015) 0.93
Identification of 50 class D β-lactamases and 65 Acinetobacter-derived cephalosporinases in Acinetobacter spp. Antimicrob Agents Chemother (2013) 0.92
A truncated AdeS kinase protein generated by ISAba1 insertion correlates with tigecycline resistance in Acinetobacter baumannii. PLoS One (2012) 0.91
Antimicrobial resistance in Acinetobacter baumannii: From bench to bedside. World J Clin Cases (2014) 0.88
Genomewide overexpression screen for fosfomycin resistance in Escherichia coli: MurA confers clinical resistance at low fitness cost. Antimicrob Agents Chemother (2012) 0.88
The characteristics of metallo-β-lactamase-producing gram-negative bacilli isolated from sputum and urine: a single center experience in Korea. Yonsei Med J (2011) 0.86
Genetic and functional variability of AmpC-type β-lactamases from Acinetobacter baumannii. Antimicrob Agents Chemother (2010) 0.85
Effect of chlorine exposure on the survival and antibiotic gene expression of multidrug resistant Acinetobacter baumannii in water. Int J Environ Res Public Health (2014) 0.84
Emergence of concurrent infections with colistin-resistant ESBL-positive Klebsiella pneumoniae and OXA-23-producing Acinetobacter baumannii sensitive to colistin only in a Romanian cardiac intensive care unit. Eur J Clin Microbiol Infect Dis (2015) 0.83
Carbapenem Resistance in Acinetobacter baumannii and Other Acinetobacter spp. Causing Neonatal Sepsis: Focus on NDM-1 and Its Linkage to ISAba125. Front Microbiol (2016) 0.83
Biological features of biofilm-forming ability of Acinetobacter baumannii strains derived from 121 elderly patients with hospital-acquired pneumonia. Clin Exp Med (2014) 0.79
Imipenem-resistant Acinetobacter baumannii carrying the ISAba1-bla OXA-23,51 and ISAba1-bla ADC-7 genes in Monteria, Colombia. Braz J Microbiol (2012) 0.79
Detection of multi drug resistant bacteria in major hospitals in Kano, North-West, Nigeria. Braz J Microbiol (2014) 0.78
Quantitative assessment of insertion sequence impact on bacterial genome architecture. Microb Genom (2016) 0.77
Immunoprotective Efficacy of Acinetobacter baumannii Outer Membrane Protein, FilF, Predicted In silico as a Potential Vaccine Candidate. Front Microbiol (2016) 0.77
Acquired Class D β-Lactamases. Antibiotics (Basel) (2014) 0.77
High Prevalence of Diverse Insertion Sequences within the rRNA Operons of Mycoplasma bovis. Appl Environ Microbiol (2016) 0.76
Carbapenem resistance and acquired class D beta-lactamases in Acinetobacter baumannii from Croatia 2009-2010. Eur J Clin Microbiol Infect Dis (2013) 0.76
Comparative Phosphoproteomics Reveals the Role of AmpC β-lactamase Phosphorylation in the Clinical Imipenem-resistant Strain Acinetobacter baumannii SK17. Mol Cell Proteomics (2015) 0.76
TEM-187, a new extended-spectrum β-lactamase with weak activity in a Proteus mirabilis clinical strain. Antimicrob Agents Chemother (2013) 0.75
Mutations Decreasing Intrinsic β-Lactam Resistance Are Linked to Cell Division in the Nosocomial Pathogen Acinetobacter baumannii. Antimicrob Agents Chemother (2016) 0.75
Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options. Front Cell Infect Microbiol (2017) 0.75
Immunoprotective potential of BamA, the outer membrane protein assembly factor, against MDR Acinetobacter baumannii. Sci Rep (2017) 0.75
Genetics and expression of the carbapenem-hydrolyzing oxacillinase gene blaOXA-23 in Acinetobacter baumannii. Antimicrob Agents Chemother (2007) 2.30
Resistance to cefepime and cefpirome due to a 4-amino-acid deletion in the chromosome-encoded AmpC beta-lactamase of a Serratia marcescens clinical isolate. Antimicrob Agents Chemother (2004) 1.54
Multicenter evaluation of the MB/BACT system for susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol (2004) 1.44
Mucosal IL-10 and TGF-beta play crucial roles in preventing LPS-driven, IFN-gamma-mediated epithelial damage in human colon explants. J Clin Invest (2008) 1.38
Identification of the novel narrow-spectrum beta-lactamase SCO-1 in Acinetobacter spp. from Argentina. Antimicrob Agents Chemother (2007) 1.07
Nosocomial outbreak of carbapenem-resistant Enterobacter cloacae highlighting the interspecies transferability of the blaOXA-48 gene in the gut flora. J Antimicrob Chemother (2012) 1.06
Most Escherichia coli strains overproducing chromosomal AmpC beta-lactamase belong to phylogenetic group A. J Antimicrob Chemother (2007) 1.02
Detection of an IS21 insertion sequence in the mexR gene of Pseudomonas aeruginosa increasing beta-lactam resistance. FEMS Microbiol Lett (2004) 0.99
Real-time PCR assay for the detection and quantification of Legionella pneumophila in environmental water samples: utility for daily practice. Int J Hyg Environ Health (2007) 0.98
Legionella pneumophila Arthritis: use of medium specific for Mycobacteria for isolation of L. pneumophila in culture of articular fluid specimens. Clin Infect Dis (2002) 0.96
Surgical-site infection after cardiac surgery: incidence, microbiology, and risk factors. Infect Control Hosp Epidemiol (2005) 0.95
Eradication of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit: which measures for which success? Am J Infect Control (2009) 0.94
Occurrence of ST23 complex phylogroup A Escherichia coli isolates producing extended-spectrum AmpC beta-lactamase in a French hospital. Antimicrob Agents Chemother (2010) 0.93
Epidemiology of Escherichia coli clinical isolates producing AmpC plasmidic beta-lactamase during a 5-year period in a French teaching Hospital. Diagn Microbiol Infect Dis (2010) 0.92
Orthopaedic-implant infections by Escherichia coli: molecular and phenotypic analysis of the causative strains. J Infect (2011) 0.88
Comparison of three methods to study biofilm formation by clinical strains of Escherichia coli. Diagn Microbiol Infect Dis (2013) 0.87
Comparison of two RT-PCR methods for quantifying ampC specific transcripts in Escherichia coli strains. FEMS Microbiol Lett (2003) 0.86
Detection of clonally related Escherichia coli isolates producing different CMY β-lactamases from a cystic fibrosis patient. J Antimicrob Chemother (2013) 0.86
Imipenem-resistant Pseudomonas aeruginosa gastrointestinal carriage among hospitalized patients: risk factors and resistance mechanisms. Diagn Microbiol Infect Dis (2009) 0.85
Antibiotic innovation may contribute to slowing the dissemination of multiresistant Streptococcus pneumoniae: the example of ketolides. PLoS One (2008) 0.83
Klebsiella pneumoniae clinical isolate coproducing SHV-2a, DHA-1, QnrB4, and AAC(6')-Ib-cr determinants in France. Diagn Microbiol Infect Dis (2009) 0.82
Effect of zinc gluconate on propionibacterium acnes resistance to erythromycin in patients with inflammatory acne: in vitro and in vivo study. Eur J Dermatol (2005) 0.81
Occurrence and molecular characterization of Klebsiella pneumoniae ST37 clinical isolates producing plasmid-mediated AmpC recovered over a 3-year period. Diagn Microbiol Infect Dis (2012) 0.81
Bacterial and epidemiologic study of the resistance to oxyiminocephalosporins in Escherichia coli in a French hospital. Clin Microbiol Infect (1999) 0.81
Increased resistance to beta-lactams in a Klebsiella pneumoniae strain: role of a deletion downstream of the Pribnow box in the blaSHV-1 promoter. Int J Antimicrob Agents (2006) 0.81
16S rRNA gene pyrosequencing reveals shift in patient faecal microbiota during high-dose chemotherapy as conditioning regimen for bone marrow transplantation. Microb Ecol (2014) 0.80
Chitinophaga terrae bacteremia in human. Emerg Infect Dis (2009) 0.79
Investigation and management of multidrug-resistant Acinetobacter baumannii spread in a French medical intensive care unit: one outbreak may hide another. Am J Infect Control (2012) 0.79
Relapse of Serratia marcescens sternal osteitis 15 years after the first episode. J Clin Microbiol (2011) 0.79
Vitek2 system: a reliable tool to detect qnr determinants in Enterobacteriaceae without quinolone resistance-determining region modifications. Diagn Microbiol Infect Dis (2009) 0.79
Randomized comparison of serum teicoplanin concentrations following daily or alternate daily dosing in healthy adults. Antimicrob Agents Chemother (2004) 0.78
Risk factors for mortality in patients with mediastinitis after cardiac surgery. Arch Cardiovasc Dis (2009) 0.78
Outbreak caused by Proteus mirabilis isolates producing weakly expressed TEM-derived extended-spectrum β-lactamase in spinal cord injury patients with recurrent bacteriuria. Scand J Infect Dis (2011) 0.77
Gallibacterium anatis bacteremia in a human. J Clin Microbiol (2013) 0.77
In vitro activities of a new lipopeptide, HMR 1043, against susceptible and resistant gram-positive isolates. Antimicrob Agents Chemother (2003) 0.76
Clinical efficacy and time to symptom resolution of 5-day telithromycin versus 10-day amoxicillin-clavulanate in the treatment of acute bacterial sinusitis. Curr Med Res Opin (2008) 0.76
Fatal coinfection with Legionella pneumophila serogroup 8 and Aspergillus fumigatus. Diagn Microbiol Infect Dis (2007) 0.75
Anaerobes isolated from bone and joint infections and their susceptibility to antibiotics. J Infect (2012) 0.75
TEM-187, a new extended-spectrum β-lactamase with weak activity in a Proteus mirabilis clinical strain. Antimicrob Agents Chemother (2013) 0.75
In vivo selection of an Escherichia coli isolate highly resistant to ciprofloxacin and ceftazidime: role of a 4-bp duplication in acrR and ampC overexpression. Int J Antimicrob Agents (2008) 0.75
Emergence of high ampicillin-resistant Enterococcus faecium isolates in a kidney transplant ward: role of antibiotic pressure and cross transmission. Microb Drug Resist (2010) 0.75
[Study of the consumption of alcohol-based disinfectants]. Soins (2011) 0.75
Escherichia coli-induced productions of pro-inflammatory cytokines are regulated by MAP kinases and G-protein but not by Akt: Relationship with phylogenetic groups and resistance patterns. Cytokine (2011) 0.75
Influence of the AtlE autolysin on the activity of cell wall-active agents against Staphylococcus epidermidis. Int J Antimicrob Agents (2009) 0.75
Genotypic and phenotypic characterization of Staphylococcus epidermidis causing chronic relapsing prosthetic joint infections. Scand J Infect Dis (2012) 0.75